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Novel Mechanism of Regulation of Tomato Bushy Stunt Virus
Replication by Cellular WW-Domain Proteins
Daniel Barajas,a Nikolay Kovalev,a Jun Qin,a,b Peter D. Nagya
Department of Plant Pathology, University of Kentucky, Lexington, Kentucky, USAa; College of Life Science, Northwest A&F University, Yangling, Shaanxi, People’s Republic
of Chinab
ABSTRACT
Replication of ()RNA viruses depends on several co-opted host proteins but is also under the control of cell-intrinsic restric-
tion factors (CIRFs). By using tombusviruses, small model viruses of plants, we dissect the mechanism of inhibition of viral rep-
lication by cellular WW-domain-containing proteins, which act as CIRFs. By using fusion proteins between the WW domain
and the p33 replication protein, we show that the WW domain inhibits the ability of p33 to bind to the viral RNA and to other
p33 and p92 replication proteins leading to inhibition of viral replication in yeast and in a cell extract. Overexpression of WW-
domain protein in yeast also leads to reduction of several co-opted host factors in the viral replicase complex (VRC). These host
proteins, such as eEF1A, Cdc34 E2 ubiquitin-conjugating enzyme, and ESCRT proteins (Bro1p and Vps4p), are known to be in-
volved in VRC assembly. Simultaneous coexpression of proviral cellular factors with WW-domain protein partly neutralizes the
inhibitory effect of the WW-domain protein. We propose that cellular WW-domain proteins act as CIRFs and also as regulators
of tombusvirus replication by inhibiting the assembly of new membrane-bound VRCs at the late stage of infection. We suggest
that tombusviruses could sense the status of the infected cells via the availability of cellular susceptibility factors versus WW-
domain proteins for binding to p33 replication protein that ultimately controls the formation of new VRCs. This regulatory
mechanism might explain how tombusviruses could adjust the efficiency of RNA replication to the limiting resources of the host
cells during infections.
IMPORTANCE
Replication of positive-stranded RNA viruses, which are major pathogens of plants, animals, and humans, is inhibited by several
cell-intrinsic restriction factors (CIRFs) in infected cells. We define here the inhibitory roles of the cellular Rsp5 ubiquitin ligase
and its WW domain in plant-infecting tombusvirus replication in yeast cells and in vitro using purified components. The WW
domain of Rsp5 binds to the viral RNA-binding sites of p33 and p92 replication proteins and blocks the ability of these viral pro-
teins to use the viral RNA for replication. The WW domain also interferes with the interaction (oligomerization) of p33 and p92
that is needed for the assembly of the viral replicase. Moreover, WW domain also inhibits the subversion of several cellular pro-
teins into the viral replicase, which otherwise play proviral roles in replication. Altogether, Rsp5 is a CIRF against a tombusvirus,
and it possibly has a regulatory function during viral replication in infected cells.
Plus-stranded ()RNA viruses, which are widespread andemerging pathogens, replicate in the cytosol of infected cells
by assembling membrane-bound viral replicase complexes
(VRCs). The VRCs consist of the viral RNA and viral proteins, as
well as co-opted host-coded proteins (1–8). Rapid progress has
recently been made in understanding the functions of the viral
replication proteins, including the viral RNA-dependent RNA
polymerase (RdRp) and auxiliary replication proteins, and yet the
functions of many subverted host proteins in VRC assembly are
less well characterized (9, 10). The growing list of subverted host
proteins contributing to VRC assembly includes translation fac-
tors, protein chaperones, RNA-modifying enzymes, and cellular
proteins involved in lipid biosynthesis (11–15). The cellular
ESCRT proteins, reticulons, and amphiphysins could be involved
in membrane deformation occurring during VRC assembly (4, 16,
17). Altogether, it seems that the VRC assembly is a rather com-
plex process driven by many factors; thus, it is likely regulated by
viral and host factors for optimal replication in infected cells.
In addition to the subverted cellular proteins helping viral rep-
lication as susceptibility factors, many host proteins have been
identified, which act as cell-intrinsic restriction factors (CIRFs)
(11–15, 18–22). These factors might be components of the innate
immune responses and used by the host for antiviral defense
(23–26) or utilized by viruses as regulatory factors to keep the
replication process under control (27).
Tomato bushy stunt virus (TBSV) is a small ()RNA virus of
plants. TBSV is used to study virus-host interactions using yeast
(Saccharomyces cerevisiae) as a model host (5, 28–31). The auxil-
iary p33 replication protein, which is an RNA chaperone, recruits
the TBSV ()RNA to the site of replication, which occurs at the
cytosolic surface of peroxisomal membranes (27, 32–36). The in-
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teraction between the RdRp protein p92pol and the p33 replication
protein is required for assembling the functional VRCs (30, 34,
37–39).
A dozen systematic genome-wide screens and global proteom-
ics approaches in yeast or in vitro have led to the identification of
500 host proteins/genes involved in TBSV replication. The host
proteins interacted with the viral replication proteins and viral
RNA or affected TBSV replication and recombination when de-
leted/downregulated or overexpressed in host cells (11, 13, 40–
48). Cataloging of the host factors affecting TBSV replication is
one of the most complete among pathogens at a single cell level,
thus facilitating mechanistic studies.
Several co-opted host factors are known to be involved in the
assembly of the membrane-bound VRCs of tombusviruses. These
proteins include the host heat shock protein 70 (Hsp70), the eu-
karyotic elongation factor 1A (eEF1A), Vps23p ESCRT (endo-
somal sorting complexes required for transport) protein, Bro1p
ESCRT-associated protein, and Vps4p AAA ATPase (39, 46, 47,
49–59). Cdc34p E2 ubiquitin-conjugating enzyme binds to p33,
and it functions as a permanent member of the viral VRC, affect-
ing the activity of the VRC (47).
Pex19p peroxisomal transport protein binds to p33 and pro-
motes the recruitment of p33 to the peroxisomes (32, 36, 60).
Interestingly, the Pex19p-p33 interaction is not essential for TBSV
replication and, in the absence of Pex19p, p33 is recruited to the
ER via another unidentified host protein/pathway (32, 60).
Other subverted cellular proteins are involved in viral RNA
synthesis. The list includes eEF1A, the eukaryotic elongation fac-
tor 1B (eEF1B), the DDX3-, DDX5-, and eIF4AIII-like DEAD
box helicases, and Tdh2p (GAPDH [glyceraldehyde-3-phosphate
dehydrogenase]), all of which facilitate RNA replication (51, 53,
59, 61–63).
To test the possible regulatory functions of recruited cellular
proteins, we chose the WW-domain-containing cellular proteins
(64). The yeast Nedd4-type Rsp5p E3 ubiquitin ligase carrying
WW domain was identified in several genome-wide screens pre-
viously (13, 42, 48). In addition to Rsp5p, several cellular WW-
domain proteins, including Wwm1p, Prp40p, and plant AtDrh1,
AtFCA, and AtPrp40c, bind to the tombusvirus replication pro-
teins and inhibit their functions (64, 65). Accordingly, binding of
Rsp5p and other WW-domain proteins to the p92pol replication
protein leads to the degradation of p92pol (64, 65).
The WW domain is a simple and highly conserved protein
domain involved in protein-protein interactions (66, 67). The se-
quences of WW domains are highly variable (except from the
conserved residues), which likely affect substrate specificity (66).
The canonical WW domain contains two signature tryptophan
residues and a conserved proline residue, which are part of a glob-
ular fold with three beta-sheets. WW-domain proteins, which are
represented by multiple proteins in various organisms, including
humans, bind to ligands usually carrying proline-rich sequences
(66).
In the present study, we dissected the detailed function of the
WW-domain proteins in viral replication. We show that the ex-
pression of the WW-domain protein interfered with complex for-
mation between the p33 replication protein and several cellular
proteins that act as susceptibility factors during TBSV replication.
In addition, the WW domain inhibited the binding of p33 to the
viral RNA and p33-p33 self-interaction in yeast. We also show that
the WW domain can efficiently block tombusvirus replication in
yeast or in a cell-free replication assay. We propose models on the
CIRF activity and regulatory role of the WW-domain proteins in
controlling TBSV replication via inhibition of VRC assembly at
the late stage of replication.
MATERIALS AND METHODS
Yeast strains and plasmids. The Saccharomyces cerevisiae strain BY4741
(MATa his31 leu20 met150 ura30) was obtained from Open Biosys-
tems. Yeast strains expressing C-terminal hemagglutinin (HA)-tagged
proteins were made by homologous recombination using BY4741 as a
parental strain. PCRs for 3HA tagging of SSA1, TEF1, and TDH2 were
performed with the primer pairs 5075/2947, 5076/5077, and 5078/5079,
respectively, using plasmid pYM-24 (Euroscarf) as the template. PCRs for
6HA tagging of CDC34, PEX19, and VPS4 were performed with the
primer pairs 5080/5081, 5180/5181, and 3258/3259, respectively, using
plasmids pYM-14 (Euroscarf) as the template for CDC34 and PEX19 and
pYM-16 for VPS4. The obtained PCR products were transformed into
BY4741 strain. Recombinant yeasts were selected on YPD plates supple-
mented with hygromycin or with G418-Geneticin. The BRO1-6HA
strain has been described before (4).
To create the yeast strain GAL1-CDC34, containing an extra copy of
CDC34, whose expression driven by the GAL1 promoter integrated at
retrotransposon sites, CDC34 sequence was PCR amplified with the
primer pair 1846/1847. The PCR product was digested with BglII and
XhoI and ligated into BamHI/XhoI-digested pESC-HIS (Agilent Technol-
ogies). The cassette comprising GAL1::CDC34-CYCt was amplified with
the primer pair 3874/3654. The resulting product was digested with BglII
and ligated to BglII-digested pFA6-hphNT1 (Euroscarf). The ligation was
used as the template for PCR with the primers 3653 and 3654. The result-
ing PCR product was transformed into yeast strain BY4741. Recombinant
yeast was selected on yeast extract-peptone-dextrose plates supplemented
with hygromycin.
Plasmids pGBK-Hisp33-CUP1/DI72-GAL1, pGAD-His92-CUP1,
pGAD-Flag92-CUP1, and pGBK-His33-CUP1 have been described be-
fore (47, 64, 68). To create plasmid pGAD-CFP-p92-CUP1, the 6His-
CFP-p92 cassette was amplified by PCR with the primers 807 and 952
using plasmid pGAD-CFP-p92 as the template (34). The PCR product
was digested with NcoI and XhoI and ligated to pGAD-His92-CUP1 pre-
viously digested with NcoI and XhoI. To create pGBK-CFP-p33-CUP1,
the 6His-CFP-p33 cassette was PCR amplified with the primers 807 and
992B from plasmid pGBK-His-CFP-p33 (34). The product was digested
with NcoI and PstI and ligated into pGBK-His33-CUP1 previously di-
gested with NcoI and PstI.
To make plasmid pGAD-WW-p92-CUP1, the RSP5 WW region was
PCR amplified from plasmid pYES-Rsp5 (64) with the primers 3045 and
2800 and then digested with BglII and NheI, while the CNV p92 open
reading frame (ORF) was PCR amplified with the primers 2261 and 952
and digested with SpeI. The two PCR products were ligated together with
pYES2/NT/C digested with BamHI. The ligation product was used as the
template for PCR with the primers 807 and 952. The resulting product was
digested with NcoI and XhoI and ligated into NcoI/XhoI-digested pGAD-
His92-CUP1. To make pGBK-WW-p33-CUP1, a similar strategy was
used except that CNV p33 was PCR amplified with the primers 2261 and
992B. After ligation with pYES2/NT/C and RSP5-WW, the cassette was
amplified with the primers 807 and 992B digested with NcoI and PstI and
ligated into NcoI/PstI-digested pGBK-His33-CUP1.
The plasmid pESC-HisYFP-p33-GAL1/DI-72-GAL10 has been de-
scribed (32). To create pESC-WW-YFP-p33-GAL1/DI-72-GAL10, the
WW region of RSP5 was PCR amplified with the primers 4937 and 4608
and then digested with BglII. YFP was PCR amplified with the primers
1291 and 4938 and then digested with BamHI. The two digested PCR
products were ligated and reamplified by PCR with the primers 4937 and
4938, digested with NcoI and BglII, and ligated into NcoI/BamHI-di-
gested pESC-His-p33-GAL1/DI-72-GAL10 (60). Plasmid pGAD-pex13-
CFP has been described elsewhere (34).
WW-Domain Protein Acts as Restriction Factor for TBSV
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pMAL-p33, expressing the maltose-binding protein (MBP) fused with
TBSV p33, was made as follows. The TBSV p33 ORF was PCR amplified
with the primers 788 and 2744. The PCR product was digested with
BamHI and PstI and ligated into BamHI/PstI-digested pMALc2x (New
England Biolabs). To make pMAL-p92, TBSV p92 was PCR amplified
with the primers 4688 and 826, digested with EcoRI and XhoI, and ligated
into EcoRI/SalI-digested pMALc2x. To make pMAL-WW-p33, the WW
region of RSP5 was PCR amplified with the primers 2805 and 4608, di-
gested with EcoRI and BglII, and ligated into EcoRI/BamHI-digested
pMAL-p33. To make pMAL-WW-p92, the WW region of RSP5 was PCR
amplified with the primers 2805 and 4608 and digested with BglII. TBSV
p92 was PCR amplified with the primers 4619 and 826 and digested with
BglII. The two PCR products were ligated together and reamplified with PCR
using the primers 2805 and 826. The product was digested with EcoRI and
XhoI and ligated into EcoRI/XhoI-digested pMALc2x.
pMAL constructs expressing truncated versions of TBSV p33 fused to
MBP have been described before (69). pMAL-p33c-RPR was made as
follows. TBSV p33 (amino acids [aa] 168 to 209) was PCR amplified with
the primers 48 and 1134 and digested with XbaI. TBSV p33 (aa 221 to 296)
was PCR amplified with the primers 3564 and 10 and digested with NheI.
The two PCR products were ligated and reamplified with PCR using prim-
ers 48 and 10. The obtained PCR product was digested with BamHI and
XbaI and ligated into pMALc2x digested with BamHI and XbaI. pMAL–
p33-RPR was made using a similar strategy. TBSV p33 (aa 1 to 209) was
PCR amplified with the primers 788 and 1134, digested with XbaI, and
ligated with NheI-digested TBSV p33 (aa 221 to 296) product. The liga-
tion products were used for PCR with the primers 788 and 10. The gen-
erated PCR product was digested with EcoRI and XbaI and ligated into
EcoRI/XbaI-digested pMALc2x. The plasmid pGEX-His-Rsp5, for ex-
pression of GST (glutathione S-transferase)-His6-Rsp5p in Escherichia
coli, has been described before (64).
The plasmid pESC-URA (Agilent Technologies) was modified to re-
place the GAL10 promoter with the ADH1 promoter. To do so, the GAL1
promoter was amplified by PCR with the primers 1147 and 5002. The
ADH1 promoter was amplified with the primers 953 and 5003, using
pGAD-His92 as the template (30). The resulting PCR products were di-
gested with Bsp1407I, ligated together, and reamplified with PCR using
the primers 5002 and 5003. The PCR product was digested with BamHI
and EcoRI and ligated into BamHI/EcoRI-digested pESC-URA.
To create pESC-His-WW-GAL1/ADH1, a cassette comprising the
GAL1 promoter and the His6-tagged WW region of RSP5 was obtained by
PCR using pYES-Rsp5 (64) with the primers 1147 and 2800. The ADH1
promoter was PCR-amplified with the primers 953 and 5003 as described
above. The two PCR products were digested with Bsp1407I, ligated to-
gether, and reamplified with PCR using the primers 2800 and 5003. The
generated PCR product was digested with XhoI and NotI and ligated into
XhoI/NotI-digested pESC-URA. The His6-tagged YFP, SSA1, TEF1, and
TDH2 were PCR amplified with the primers 5035/5036, 4960/4961, 4958/
4959, and 5090/5005, respectively. The obtained PCR products were di-
gested with NotI and SacI and ligated into NotI/SacI-digested pESC-
GAL1/ADH1 or into pESC-HisWW-GAL1/ADH1.
For the YTH-based studies, we created plasmid pGBK-p33C carrying
the C-terminal half (aa 168 to 296) of TBSV p33 ORF. The cDNA of TBSV
p33 ORF was PCR amplified with the primers 183 and 1593, digested with
EcoRI and XhoI, and ligated into EcoRI/SalI-digested pGBK-T7 (Clon-
tech). Similarly, the EcoRI/XhoI-digested p33C PCR product was ligated
into EcoRI/XhoI-digested pGAD-T7 (Clontech) to generate pGAD-
p33C. To create pGAD-WW-p33C, the WW region of RSP5 was PCR
amplified with the primers 2805/4608 and digested with BglII. The TBSV
p33C (aa 168 to 296) was PCR amplified with the primers 633/1593 and
digested with BamHI. The two PCR products were ligated together and
reamplified with PCR using the primers 2805 and 1593. The resulting PCR
product was digested with EcoRI and XhoI and ligated into EcoRI/XhoI-
digested pGAD-T7.
To generate plasmid pYES-CypA, expressing the human His6-tagged
cyclophilin A (CypA) protein from the GAL1 promoter, a PCR was per-
formed with the primers 5031 and 5032 to amplify CypA sequences. The
PCR product was digested with BamHI and XhoI and ligated into simi-
larly digested pYES2/NT/C. The tetratricopeptide repeat (TPR) domain
of the yeast CPR7 was amplified with the primers 3195 and 3196, digested
with BamHI and XhoI, and ligated into equally digested pESC-GAL1/
ADH1 to generate pESC-His-TPR-GAL1/ADH1.
Analysis of TBSV replication and p33 and p92 expression in yeast.
Yeast strain BY4741 was transformed with plasmids pGBK-His33-CUP1/
DI72-GAL1 and pGAD-His92-CUP1 or combinations of CFP-tagged
p33/p92 or WW-tagged p33/p92. Transformed yeasts were cultured in SC
medium supplemented with 2% galactose for 16 h at 29°C. CuSO4 was
then added to a final concentration of 50 M, and the cultures were
incubated for 24 h at 29°C as previously described (64). The total RNA was
extracted, and the accumulation of DI-72 ()replicon RNA
[()repRNA] was analyzed by Northern blotting. The level of 18S rRNA
accumulation was used for normalization (30). Alternatively, BY4741 was
transformed with plasmids pESC-hisYFP-p33-GAL1/DI-72-GAL10 or
pESC-WW-YFP-p33-GAL1/DI-72-GAL10 plus pGAD-FLAGp92-CUP1;
the transformed yeasts were then grown as described above, and the ac-
cumulation of DI-72 ()repRNA was analyzed by Northern blotting (30).
For the analysis of TBSV repRNA replication in yeast overexpressing
WW and other host proteins, BY4741 was transformed with plasmids
pGBK-His33-CUP1/DI72-GAL1, pGAD-His92-CUP1, and pESC-GAL1/
ADH1 plasmids coexpressing His6-tagged WW and other host proteins.
Transformed yeasts were pregrown in liquid medium supplemented with
2% glucose for 16 h at 29°C, washed in 2% galactose medium, and used to
inoculate 2% galactose cultures (the starting optical density at 600 nm was
0.3). These cultures were incubated for 8 h at 29°C and then supplemented
with 50 M CuSO4, followed by incubation for an additional 24 h at 29°C.
The accumulation of p33 and p92 viral replication proteins was ana-
lyzed by Western blotting. Total proteins were extracted from the aliquots
of cultures used to analyze repRNA by using NaOH and SDS-PAGE load-
ing buffer, as described previously (30). Proteins were detected by using
anti-His antibody, followed by alkaline phosphatase-conjugated anti-
mouse antibody and NBT-BCIP detection (30). p33 and p92 mRNAs were
detected by Northern blotting as described previously (64).
In vivo protein-protein interaction assays. Yeast two-hybrid assays
were performed as described previously (70).
Confocal microscopy. Yeast strain BY4741 was cotransformed with
plasmids pESC-HisYFP-p33-GAL1/DI-72-GAL10 and pGAD-pex13-
CFP or plasmids pESC-WW-YFP-p33-GAL1/DI-72-GAL10 and pGAD-
pex13-CFP (32). Transformed yeast colonies were grown in SC minimal
medium supplemented with 2% galactose at 23°C for 24 h. Confocal laser
microscopy was performed as previously described (32).
Copurification of selected host factors with the tombusvirus repli-
case from yeast. Yeast strains expressing HA-tagged host proteins from
their chromosomal locations were transformed with plasmids pGBK-
Hisp33-CUP1/DI72-GAL1 or pGBK-FLAGp33-CUP1/DI72-GAL1, plus
pGAD-His92-CUP1 and pYES2/NT/C or pYES-Rsp5-WW1-3 (64).
Transformed yeasts were pregrown for 16 h at 29°C in SC minimal me-
dium containing 2% glucose and 100 M Bathocuproine disulfonate
(BCS; Acros Organics) to chelate the copper ions in the media. Cultured
yeasts were transferred to SC medium supplemented with 2% galactose
and 100 M BCS, followed by incubation for 8 h at 29°C. The yeasts were
then transferred to SC medium supplemented with 2% galactose and 5
M CuSO4, followed by incubation for an additional 24 h at 29°C. The
cultures were centrifuged, washed with phosphate-buffered saline (PBS),
and incubated in PBS plus 1% formaldehyde for 1 h on ice to cross-link
proteins. Formaldehyde was quenched by addition of glycine (0.1 M final
concentration), and the yeast was recovered by centrifugation. The viral
replicase complex was purified as described previously (47) based on
FLAG-tagged p33 replication protein using anti-FLAG M2 agarose. Puri-
fied p33 was analyzed by Western blotting with anti-FLAG antibody, fol-
lowed by anti-mouse antibody conjugated to alkaline phosphatase. Co-
Barajas et al.
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purified HA-tagged host proteins were analyzed with anti-HA antibody,
followed by alkaline phosphatase-conjugated anti-rabbit antibody and
detection with NBT-BCIP as described previously (4, 30).
TBSV replication in yeast cell extracts. Cell-free extracts (CFE) from
yeast strain BY4741 were prepared as described previously (56). The
MBP-tagged proteins were purified from E. coli as described previously
(69). The in vitro CFE assays were carried out with 0.1 g of each purified
protein, 0.5 g of in vitro-transcribed DI-72 ()repRNA, and 2 l of CFE
in a 20-l final volume. The mixtures were incubated at 25°C for 3 h, and
the amount of newly synthesized 32P-labeled repRNA was analyzed in
denaturing polyacrylamide/urea gels as described previously (56).
In another set of experiments, affinity-purified GST or GST-tagged
WW-domain, Rsp5p, and Prp40p proteins (5 pmol, each) were added
directly to CFE assay, or these proteins were preincubated with MBP-p33
for 10 min at room temperature; then, all other components (not includ-
ing MBP-p33) were added. The mixtures were incubated at 25°C for 3 h,
and the amount of newly synthesized 32P-labeled repRNA was analyzed in
denaturing polyacrylamide/urea gels as described previously (56). Each
experiment was repeated three times.
Analysis of membrane association of p33 replication protein. Mem-
brane fractionation was performed according to the same procedure for
membrane-enriched fractions described elsewhere (64). Briefly, BY4741
yeast transformed with plasmids pESC-hisYFP-p33-GAL1/DI-72-GAL10
or pESC-WW-YFP-p33-GAL1/DI-72-GAL10 plus pGAD-Hisp92 was
grown in 2% glucose minimum medium for 16 h at 29°C, transferred to
2% galactose medium, and then grown for 24 h at 29°C. Yeasts were
collected by centrifugation, resuspended in buffer E, and broken with
glass beads. Unbroken cells were removed by low-speed centrifugation
(100  g for 5 min). Membrane fractions were pelleted by centrifugation
at 15,000  g for 20 min. Both the membrane fractions and the superna-
tant were used to analyze His6-YFP-p33 and WW-YFP-p33 accumulation
by SDS-PAGE and Western blotting with anti-His antibody.
In vitro protein-protein interaction assays. Pulldown assays were
performed as previously described (64). Briefly, the MBP-tagged TBSV
p33, expressed in E. coli, was bound to amylose columns. Lysates of E. coli
expressing recombinant GST-His6-Rsp5p were then passed through the
columns. After washing, MBP-tagged proteins were eluted with maltose.
The amount of GST-His6-Rsp5p bound to MBP-tagged p33 was analyzed
by SDS-PAGE and Western blotting with anti-His antibody as described
previously (64).
In vitro RNA-protein binding assays. Electrophoresis mobility shift
assays (EMSA) were performed as described previously (69). Briefly, re-
action mixtures contained 5 ng of 32P-labeled DI-72 ()RNA plus 50,
200, or 500 ng of purified MBP-tagged proteins. After incubation for 15
min at 25°C, samples were placed on ice and run on nondenaturing 5%
polyacrylamide gels.
In another set of EMSA, we used GST (10 pmol) or GST-tagged
Prp40p, Rsp5p, and WW-domain proteins (two values for each, 5 and 10
pmol), which were preincubated for 10 min at room temperature with
MBPp33C (5 pmol), and then all other components were added [includ-
ing 0.1 pmol of 32P-labeled ()DI-72]. After incubation for 15 min at
25°C, the samples were placed on ice and run on nondenaturing 5% poly-
acrylamide gels. Each experiment was repeated twice.
In vitro replicase assay. Yeast strains R1158 (wild type [wt] for yTHC
library series) (41) and 3WW (wwm1/Tet::RSP5/Tet::PRP40) (65)
were cotransformed with plasmids pGBK-CUP1-Flag-p33/GAL1-DI72
and pGAD-Cup-Flag-p92, and colonies were selected using SC-LH
plates. After growing in 50 ml of SC-LH medium supplemented with 2%
glucose and 1 mg/ml doxycycline for 24 h at 29°C, yeasts were pelleted,
washed with SC-LH medium supplemented with 2% galactose, and re-
suspended in 50 ml of SC-LH medium supplemented with 2% galactose,
1 mg/ml doxycycline, and 50 M CuSO4. Yeast cells were grown for 16 or
64 h at 29°C and then pelleted. About 200 mg of pellet was used to isolate
tombusvirus replicase (based on Flag-p33 and Flag-p92) with anti-Flag
M2-agarose as described previously (49). Replicase preparations isolated
from different yeast strains were balanced and their activities were mea-
sured in vitro using ()R1/3 template in the standard RdRp assay (30).
The presence of host factors was detected by using the following primary
antibodies: anti-eEF1A, anti-eEF1B, anti-CDC34 and by using alkaline
phosphatase-conjugated anti-rabbit antibody (Sigma) and NBT-BCIP
detection (30).
Kinetic measurements with surface plasmon resonance. Kinetic
measurements were done using a BLITZ instrument (ForteBio). Briefly,
the GST-tagged yeast proteins (0.2 M) were loaded onto the GST-chip-
based biosensor for 5 min with shaking (1,000 rpm). Binding to chip was
measured in MBP-elution buffer (30 mM HEPES-KOH [pH 7.4], 25 mM
NaCl, 1 mM EDTA) at room temperature as follows. MBP-tagged pro-
teins were diluted with MBP elution buffer to 0.1 to 12 M, and 4 l of
protein was interacted with GST-tagged proteins bound to the biosensor.
Kinetic data were obtained as recommended: 30 s for baseline (buffer), 2
min for association (MBP-tagged protein), 2 min for dissociation (buf-
fer). Association rate constant (ka), dissociation rate constant (kd), and
interaction affinity constant (KD) values were calculated using the BLITZ
software. The negative control was purified MBP binding to the immobi-
lized GST-WW protein or GST-Cdc34 on the GST-chip-based biosensor.
RESULTS
Inhibition of the RNA-binding and protein-interaction func-
tions of tombusvirus replication proteins by the WW-domain
protein. Previous studies revealed that the yeast Rsp5p E3 ubiq-
uitin ligase acts as a CIRF through binding via its WW domain to
tombusvirus p33 and p92pol replication proteins and inhibits
TBSV replication in yeast and in vitro, while several WW proteins
inhibit TBSV infection in plants (64, 65). To unravel the mecha-
nism of WW-domain-protein-driven inhibition on TBSV replica-
tion, we first defined the binding site for the WW domain of Rsp5p
in the p33 replication protein using a set of truncated proteins in a
pulldown assay (Fig. 1A). These experiments defined that the argi-
nine-proline-rich (RPR) motif in p33 involved in viral RNA bind-
ing is the preferred binding site for Rsp5p WW-domain protein
(Fig. 1B and C).
To test whether Rsp5p WW-domain protein affects the ability
of p33 to bind to the viral RNA, we first expressed and purified the
WW domain of Rsp5p, the full-length Rsp5p, and Prp40, another
yeast protein with WW domain, which has moderate CIRF activ-
ity against tombusviruses (65). Using affinity-purified proteins
and 32P-labeled viral RNA, we performed an electrophoretic mo-
bility shift assay (EMSA). These experiments revealed that both
WW-domain and full-length Rsp5p completely inhibited the
RNA-binding function of p33 in vitro (Fig. 2A, lanes 7 to 10
versus lanes 1 and 2). Prp40 was less efficient inhibitor of p33
binding to RNA.
In case of the second approach, we made a fusion protein con-
taining the WW domain of Rsp5p, and the C-terminal portion of
p33, termed p33C, separated by a linker sequence (Fig. 2B). The
fusion protein strategy is used to guarantee that each p33 se-
quence can efficiently interact with the WW domain. Another
advantage of the fusion strategy is that the WW domain is
known to fold efficiently in the absence of cofactors (67, 71,
72). Using affinity-purified proteins and 32P-labeled viral RNA
in EMSA, we demonstrated that the WW domain completely
inhibited the RNA-binding function of p33 in vitro (Fig. 2C,
lanes 10 to 12 versus lanes 6 to 8).
Using a similar strategy with the fusion protein, we also showed
that the WW domain inhibited the self-interaction between p33
molecules in a yeast two-hybrid assay (Fig. 2D). Similar to the
observation with the above fusion strategy, copurification of His6-
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tagged p33 with the FLAG-p33 from membranes was inhibited by
the separate coexpression of the WW-domain protein in yeast
(Fig. 2E, lane 3 versus lane 2). Altogether, these data suggest that
the interaction of the WW domain with the C-terminal region of
p33 inhibits both the RNA-binding and p33-p33 interaction func-
tions of the viral replication protein. Because p92pol shares the
same sequence with p33 in its N-terminal region, it is likely that
the previously shown interaction between Rsp5p and p92pol (64,
65) also leads to the inhibition of the ability of p92pol to interact
with p33 and the viral RNA.
The WW domain inactivates the replication function of both
p33 and p92 in the CFE-based replication assay. To test the in-
hibitory function of the WW domain (derived from Rsp5p and
contains three WW motifs) under defined conditions in vitro, we
used the purified recombinant WW-domain protein in a CFE-
based TBSV replication assay (Fig. 3A). The TBSV repRNA can go
through a single full cycle of replication (producing double-
stranded RNA intermediate on added plus-stranded template and
excess amount of new plus-stranded RNAs) in yeast CFE when
purified recombinant p33 and p92pol replication proteins are pro-
vided (Fig. 3B, lane 1) (37, 56, 73). When WW-domain protein or
Rsp5p were added to the CFE assay, then TBSV replication was
10% of the control assay containing purified GST protein (Fig.
3B, lane 2 versus lane 1). Preincubation of the WW-domain pro-
tein and p33 replication protein did not increase further the in-
hibitory effect of the WW-domain protein (Fig. 3B, lane 6).
However, the above-described experiments did not define
whether the WW-domain protein or Rsp5p inhibited the function
of p33, p92pol, or both. Therefore, we used the fusion protein
approach in the CFE-based replication assay (Fig. 3C). When
FIG 1 Defining the sequence within the TBSV p33 protein needed for binding to the Rsp5p WW-domain protein in vitro. (A) Schematic representation of the
TBSV p33 and its truncated derivatives used in the affinity-binding assay. The various domains include the following: TMD, transmembrane domain; RPR,
arginine-proline-rich RNA-binding domain; P; phosphorylated serine and threonine; S1 and S2 subdomains involved in p33–p33/p92 interaction. (B) Affinity
binding (pulldown) assay to detect interaction between GST-His6-tagged Rsp5p and the MBP-tagged viral p33 protein derivatives. The MBP-tagged viral
proteins produced in E. coli were immobilized on amylose-affinity columns. Then, GST-His6-Rsp5p expressed in E. coli was passed through the amylose-affinity
columns with immobilized MBP-tagged proteins. The affinity-bound proteins were eluted with maltose from the columns. (Top) The eluted proteins were
analyzed by Western blotting with anti-His antibody to detect the amount of GST-His6-Rsp5p specifically bound to MBP-tagged viral proteins. (Bottom)
SDS-PAGE analysis of the purified MBP-p33 and its derivatives. (C) Pulldown assay to detect interaction between GST-His6-tagged Rsp5p and the MBP-tagged
p33CRPR protein. See further details in panel B.
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WW-p33 was provided with p92pol in the CFE assay, then TBSV
replication was undetectable (Fig. 3C, lanes 3 and 4). The WW-
p92 in combination with p33 supported a low level of TBSV RNA
replication (Fig. 3C, lanes 5 and 6), suggesting that the replication
function of p92pol is also inhibited by the fusion with the WW
domain. Altogether, these data confirmed that the WW domain
efficiently inhibits the replication functions of both p33 and p92pol
in vitro.
To test whether the WW domain makes p33 molecules domi-
nant negative (i.e., also inhibiting wt p33 or p92pol molecules that
are part of the VRCs), we added the functional p33 and p92pol,
together with WW-p33, to the CFE assay. Interestingly, we ob-
served no inhibitory effect by the WW-p33 in the CFE assay, sug-
gesting that WW-p33 had no dominant-negative effect on TBSV
replication (Fig. 3D, lanes 3 and 4 versus lanes 1 and 2). This is in
contrast with the dominant-negative effect of the p33 mutant
lacking the RPR region responsible for RNA binding (mutant
p33RPR, lanes 5 and 6, Fig. 3D) (74). The lack of dominant-
negative effect of WW domain in WW-p33 on the viral replicase
activity could be important during regulation of tombusvirus rep-
lication in infected cells (see Discussion).
Inhibition of tombusvirus replication by the WW-domain
protein in yeast. Using the fusion protein approach, we tested the
effect of the WW domain on TBSV replication to define if the
WW-domain protein inhibited the function of p33, p92pol or both
in yeast cells (Fig. 4A). Expression of WW-p33 with His6-p92 or
His6-p33 with WW-p92 completely blocked TBSV repRNA accu-
mulation (Fig. 4B, lanes 7 to 12 versus lanes 1 to 6). Western blot
analysis showed that WW-p33 accumulated in yeast (Fig. 4C,
lanes 5 and 6), suggesting that the lack of TBSV replication in the
FIG 2 WW-domain inhibits viral RNA binding by p33 in vitro. (A) For the the top image, EMSA was performed with 5 pmol of purified MBP-tagged p33C (wt,
carrying 151 to 296 aa). The 32P-labeled RNA probe was wt DI-72 ()RNA. Samples contained 10 pmol of GST (lanes 2 and 4) and 10 or 5 pmol of GST-Prp40
(lanes 5 and 6), GST-Rsp5 (lanes 7 and 8), or GST-WW domain (lanes 9 and 10), respectively. Arrows depict the bound and unbound RNA probes. For the
bottom image, SDS-PAGE, followed by Coomassie blue staining of the purified recombinant proteins used in panel A, was performed. (B) Schematic represen-
tation of the fusion protein used for expression in E. coli. The WW domain of Rsp5p containing three WW repeats and the C-terminal region of p33 (termed
p33C) containing the known RNA-binding site is shown. (C) For the top image, EMSA was performed with 1.2, 5, or 12 pmol of purified MBP, MBP-tagged
p33C, or MBP-WW-p33C. The 32P-labeled RNA probe was wt DI-72 ()RNA. Arrows depict the bound and unbound RNA probes. For the bottom image,
SDS-PAGE, followed by Coomassie blue staining of the purified recombinant proteins used in panel C, was performed. (D) Interaction between two p33
replication proteins is inhibited by the WW domain in yeast. A yeast two-hybrid assay was performed to test binding between p33C and the shown prey proteins.
The empty prey vector was used as a negative control. (E) Reduced copurification of His6-p33 with the viral replicase from yeast coexpressing His6-WW-domain
protein. The viral replicase was purified through FLAG-tagged p33 from yeast extracts by using a FLAG-affinity column. Western blot analysis of copurified
His6-p33 using anti-His antibody. Each experiment was repeated three times.
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presence of WW-p33 was likely due to the inactivation of p33
functions by the WW domain. On the other hand, WW-p92 did
not accumulate at a detectable level in yeast cells (Fig. 4C, lanes 7
and 8), suggesting that p92pol was degraded in the presence of the
WW domain, as shown previously with separately expressed pro-
teins (64, 65). Indeed, we were able to detect mRNA expression for
WW-p92 (Fig. 4B, bottom panel). In contrast, either His6-p33 and
His6-p92 or His6-CFP-p33 and His6-CFP-p92 supported TBSV
RNA accumulation efficiently (Fig. 4B, lanes 1 to 6), suggesting
that the N-terminal tags attached to p33/p92pol, which do not
interact with the p33 and p92pol sequences, do not inhibit TBSV
replication.
We also used a different fusion protein, in which the YFP se-
quence separated the WW domain from the p33 sequence (con-
struct WW-YFP-p33, Fig. 4A). This protein, when coexpressed
with p92pol, could not support TBSV repRNA accumulation in
yeast (Fig. 4D, lanes 3 to 4), confirming that the WW domain
interferes with the functions of p33 replication protein. Similar to
wt p33 (34, 75) and the YFP-p33, the WW-YFP-p33 is associated
with membranes (was inserted into the lipid bilayer) in yeast
based on fractionation and washing with 1 M NaCl, which could
remove peripheral membrane proteins (Fig. 4E). Also, confocal
microscopic analysis showed the mostly peroxisomal localization
of WW-YFP-p33 (Fig. 4F), similar to YFP-p33 (Fig. 4G) (32, 34,
60). Thus, the YFP sequence is correctly folded within the WW-
YFP-p33 fusion protein and the peroxisomal targeting sequence
and membrane association of p33 have also remained functional.
These data are in agreement with the prediction that the WW
domain precisely inactivates p33 functions, such as the RNA-
binding function, p33-p33 interaction, and p33-host protein in-
teractions, when present in the fusion protein.
Expression of the WW-domain protein decreases the
amount of copurified cellular proteins in the tombusvirus rep-
licase. To test the possible regulatory role of the WW-domain
proteins in TBSV replication, we expressed the WW domain of Rsp5p
in yeast. We chose to express only the WW domain and not the full-
length protein, since the WW domain is the functionally relevant
portion of Rsp5p during TBSV replication (65), and the presence of
the E3 ubiquitin ligase domain of Rsp5p might affect the functions of
numerous client cellular proteins when overexpressed. The same
yeast cells also coexpressed p33 and p92pol replication proteins and
the DI-72 replicon (rep)RNA and selected HA-tagged cellular pro-
teins, those which are known to function as susceptibility factors for
TBSV, from chromosomal locations. After affinity purification of the
membrane-bound tombusvirus VRCs (via purification of p33 and
p92pol), we analyzed the amount of copurified host proteins.
FIG 3 WW domain does not show dominant-negative effect on TBSV replication in a yeast cell extract. (A) Scheme of the CFE-based TBSV replication assay with
purified recombinant proteins and added TBSV DI-72 ()repRNA. All of the recombinant proteins were added simultaneously to the CFE. (B) Denaturing
PAGE analysis shows the level of repRNA accumulation in the CFE-based replication assay. The yeast cell extract (CFE) containing host factors and cellular
membranes required for TBSV replication were programmed with in vitro-synthesized DI-72 ()repRNA and purified MBP-p33, MBP-p92, and the shown
GST-tagged yeast proteins, all of which were expressed in E. coli. The reactions included [32P]UTP to detect newly synthesized DI-72 repRNA. Note that the CFE
is capable of supporting full cycle of TBSV replication, leading to asymmetrical ()RNA and ()RNA synthesis on the added ()repRNA. For the samples in
lanes 5 to 8, the GST-tagged yeast proteins were preincubated with MBP-p33 for 10 min prior to the CFE-based replication assay. (C) For the top panel,
denaturing PAGE analysis shows the level of repRNA accumulation in the CFE-based replication assay. The CFE assays were performed as in panel B, except that
purified MBP-p33 and MBP-p92 or the shown fusion proteins, all of which were expressed in E. coli, were used. For the bottom panel, SDS-PAGE, followed by
Coomassie blue staining of the purified recombinant proteins used in panel C, was performed. (D) The lack of dominant-negative effect of WW domain in the
fusion protein on the activities of p33 and p92 replication proteins in a CFE-based replication assay. See further details in panels B and C.
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FIG 4 WW domain of Rsp5p blocks TBSV RNA replication in yeast. (A) Schematic representation of the fusion proteins used for expression in yeast. The WW
domain of Rsp5p containing three WW repeats and the p33 sequence were fused as shown. The functional CFP-p33 fusion protein was chosen as control. (B) For
the top panel, Northern blot analysis to detect DI-72() repRNA accumulation in yeast coexpressing the shown combination of p33 and p92 fusion proteins was
performed. The accumulation level of DI-72() repRNA was normalized based on 18S rRNA. For the bottom panel, Northern blot analysis of p33 and p92
mRNA levels in yeast was performed. (C) Western blot analysis of total protein extracts with anti-His antibody. (D) For the top panel, Northern blot analysis to
detect DI-72() repRNA accumulation in yeast coexpressing the shown combination of p33 and p92 fusion proteins was performed. For the middle and bottom
panels, Western blot analysis of total protein extracts with anti-His or anti-Flag antibodies was performed. See further details in panels B and C. (E) Membrane
association of the various fusion proteins in yeast. Broken yeast cells were fractionated to obtain supernatant (S, soluble fraction) and membrane fraction (P,
pellet). Note that the yeast membrane fraction was washed with 1 M NaCl to remove peripheral membrane proteins. Lanes 9 and 10 represent the total, not
fractionated, proteins as standards. (F) The WW-domain–p33 fusion protein shows mostly peroxisomal localization in yeast. Confocal laser microscopy images
show the subcellular localization of WW-YFP-p33 fusion protein expressed from GAL1 promoter in the BY4741 yeast strain. The peroxisomes were visualized
with Pex13p-CFP marker. The merged images show the colocalization of WW-YFP-p33 and Pex13p-CFP marker. Differential interference contrast (DIC)
images are shown on the right. Each row represents a separate yeast cell. (G) Peroxisomal localization of YFP-p33 fusion protein. Yeast was grown under similar
conditions and images were taken as in panel F. Each experiment was repeated two to three times.
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Interestingly, the amounts of six subverted VRC-associated
host proteins decreased by 45 to 90% in the VRC preparations
purified from yeast coexpressing the WW-domain protein (Fig.
5B to G), while copurification of one host factor, the Ssa1p Hsp70,
was not affected (Fig. 5A). The largest decrease in copurification
was observed with the cellular ESCRT proteins (i.e., Vps4p and
Bro1p) and Cdc34p E2 ubiquitin-conjugating enzyme, all of
which are known to affect the assembly of the tombusvirus VRCs
(4, 47, 51). The extent of inhibition of the additional copurified
host proteins was also significant, but somewhat less pronounced
for (i) Tef1p (eEF1A) translation elongation factor known to af-
fect many viral functions, including the stability of p33, the re-
cruitment of the viral RNA, and the assembly of the VRCs and
()RNA synthesis (46, 51, 53); (ii) Tdh2p (GAPDH) involved in
()RNA synthesis (62, 63); and (iii) Pex19p cytosolic shuttle pro-
tein that targets p33 and p92pol to the peroxisomes (60). Alto-
gether, the inhibition of recruitment of multiple host factors to the
VRCs by WW-domain protein suggests a regulatory function,
possibly via competition of the WW-domain protein with these
cellular proteins for binding to p33 and p92pol. It is possible that
some of the proviral host proteins compete, while the rest of them
just being disturbed by the active binding of the ectopically ex-
pressed WW domain to p33.
Overexpression of selected cellular proteins decreases the in-
hibitory effect of the WW-domain protein on TBSV replication.
If competition for binding to p33 replication proteins exists
among the WW-domain proteins and the subverted stimulatory
host factors, then overexpression of selected stimulatory host pro-
teins is expected to neutralize the inhibitory effect of the WW-
domain proteins on TBSV replication in yeast cells. To test this
model, we individually overexpressed four stimulatory host pro-
teins in yeast, also coexpressing the WW-domain protein.
The increase of TBSV replication was 4-fold in yeast overex-
pressing both Cdc34p and the WW-domain proteins in compar-
ison with the overexpression of the WW-domain protein only
(Fig. 6A, lanes 7 and 8 versus lanes 3 and 4). Thus, overexpression
FIG 5 Reduced copurification of selected co-opted host proteins with the viral replicase from yeast coexpressing WW-domain protein. The viral replicase was
purified through FLAG-tagged p33 from yeast extracts using a FLAG-affinity column. (A to G) For the top panel, Western blot analysis of copurified HA-tagged
host protein expressed from the chromosomal location with anti-HA antibody was performed. For the middle panel, Western blot analysis of the purified
Flag-with with anti-FLAG antibody was performed. For the bottom panel, Western blot analysis of total protein extract with anti-HA antibody to detect the total
amount of the HA-tagged host protein expressed from the chromosomal location in each sample was performed. Lane 1, negative control based on yeast
expressing His6-tagged p33 and the HA-tagged host protein; lane 2, yeast coexpressing Flag-p33 and the HA-tagged host protein; lane 3, yeast coexpressing
Flag-p33 and the HA-tagged host protein in combination with WW-domain protein. All yeast strains actively replicate the TBSV repRNA (not shown). Each
experiment was repeated two to four times.
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of Cdc34p completely neutralized the strong inhibitory effect of
the overexpressed WW-domain protein. This neutralization effect
by Cdc34p likely due to efficient recruitment of the overexpressed
Cdc34p by the p33 replication protein, because Cdc34p does not
interact with Rsp5p (76). Overexpression of Ssa1p or Tef1p
slightly increased TBSV replication in wt yeast (Fig. 6B, lanes 5 and
6 and 9 and 10), while both proteins partly neutralized the inhib-
itory effect of the WW-domain protein (leading to a 2- to 2.5-fold
increase) in TBSV replication in yeast cells overexpressing the
WW-domain protein (Fig. 6B, lanes 7 and 8 and 11 and 12 versus
lanes 3 and 4). The incomplete neutralization of the inhibitory
effect by WW-domain protein could be due to the physical inter-
action between Ssa1p or Tef1p and Rsp5p (76) that might be re-
sponsible for the reduced overexpression level of both Ssa1p and
Tef1p in yeast coexpressing the WW domain of the Rsp5p protein
(Fig. 6B, lanes 4 and 6 versus lanes 3 and 5). Overexpression of the
fourth host factor, Tdh2p, had lesser neutralization effect on the
inhibitory function of the overexpressed WW-domain protein
(Fig. 6B, lanes 15 and 16). However, overexpression of Tdh2p did
not increase TBSV repRNA replication in yeast (lanes 13 and 14,
Fig. 6B), suggesting that Tdh2p is not a limiting factor in wt yeast
under the given experimental conditions.
Overexpression of the above host factors in yeast also overex-
pressing the WW-domain protein was not effective enough to
increase p33 or p92pol levels to that observed in wt yeast cells
coexpressing YFP (Fig. 6B). These observations suggest that the
overexpressed WW-domain protein is a strong competitor against
the stimulatory host factors in binding to the viral replication
protein. This could be a reason why these stimulatory host pro-
teins only had partial neutralizing effects against the inhibitory
effect of the overexpressed WW-domain protein. Altogether,
these data suggest that selected stimulatory host factors have neu-
tralizing effects on the inhibitory WW-domain protein during
TBSV replication.
Expression of the TPR-domain protein or cyclophilin A did
not inhibit the amount of copurified cellular proteins in the
tombusvirus replicase. In addition to the WW-domain-contain-
ing host factors, other cellular factors with CIRF functions might
also be involved in regulation of TBSV replication (22). To further
test the possible regulatory functions of recruited cellular pro-
teins, we chose two additional cellular CIRF factors that inhibit
TBSV replication. These were the TPR-domain-containing cellu-
lar proteins (77) and cyclophilins (45). The TPR domain from
Cyp40-like Cpr7p chaperone and the CypA (homolog of the yeast
Cpr1p) cyclophilin have been shown to bind to the tombusvirus
replication proteins (45, 65, 78).
Similar to the strategy described above with the WW-domain
protein (Fig. 5), we overexpressed either the TPR domain of
Cpr7p or CypA cyclophilin in yeast coexpressing p33 and p92pol
replication proteins, the TBSV repRNA, and selected HA-tagged
stimulatory cellular proteins from chromosomal locations (Fig.
7). After affinity purification of the membrane-bound tombusvi-
rus VRCs, we analyzed the amount of copurified stimulatory host
proteins. We found that the copurification of Cdc34p E2 ubiqui-
FIG 6 Partial recovery of TBSV RNA replication in yeast overexpressing selected subverted proviral host proteins. (A) For the top panel, Northern blot analysis
to detect DI-72() repRNA accumulation in yeast coexpressing Cdc34p and the WW-domain protein was performed. The accumulation level of DI-72()
repRNA was normalized based on 18S rRNA. To launch TBSV repRNA replication, we expressed Flag-p33 and His6-p92 from the copper-inducible CUP1
promoter and DI-72() repRNA from the galactose-inducible GAL1 promoter. While Cdc34p was expressed from GAL1 promoter from the chromosome, the
WW-domain protein (the WW domain of Rsp5p containing three WW repeats) was expressed from a plasmid based on the GAL1 promoter. For the bottom
panel, Northern blot analysis of CDC34 mRNA level before launching TBSV repRNA replication was performed. (B) For the top panel, Northern blot analysis
was used to detect DI-72() repRNA accumulation in yeast coexpressing the shown host factor (or YFP as a control) and the WW-domain protein. The
His6-WW-domain protein was expressed from GAL1 promoter from a plasmid, while the shown host susceptibility factor (also His6 tagged) was expressed from
the constitutive ADH1 promoter from the same plasmid as the WW-domain protein. See further details in panel A. For the middle and bottom panels, Western
blot analysis of total protein extracts with anti-His or anti-FLAG antibodies was performed.
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tin-conjugating enzyme, Ssa1p HSP70 chaperone, and Bro1p
ESCRT protein was not affected by the overexpression of the TPR-
domain protein or CypA cyclophilin (Fig. 7A to C, lanes 3 and 4
versus lane 2). Moreover, copurification of Pex19 shuttle protein
with the tombusviral VRC was increased from yeast expressing the
TPR domain and especially CypA protein (Fig. 7D, lanes 3 and 4).
Since Cdc34p and Bro1p cellular proteins were among those most
affected by overexpression of the WW-domain protein (Fig. 5)
and yet their recruitment into the VRCs was not affected by the
overexpression of the TPR-domain protein or CypA (Fig. 7), we
suggest that the CypA and TPR-domain proteins and the WW-
domain proteins have different regulatory roles during TBSV rep-
lication in yeast. This is surprising because, similar to the WW
domain, the TPR domain of Cpr7p and CypA also bind to the RPR
region in p33 responsible for viral RNA binding (77, 78).
The contrasting data on WW-domain protein versus cyclophi-
lins suggest that WW-domain proteins have a unique role during
TBSV replication. Nevertheless, these results indicate that WW
domain selectively affects the recruitment of stimulatory cellular
proteins into VRCs, while overexpression of the TPR-domain
protein or CypA do not detectably influence these activities.
Binding kinetics suggest a faster association of proviral cel-
lular factors to p33 than Rsp5p. In the infected cells, subverted
proviral cellular factors and antiviral restriction factors, CIRFs,
likely compete with one another for binding to the tombusvirus
replication proteins. To test the binding kinetics of selected cellu-
lar proteins to the p33 replication protein, we used surface plas-
mon resonance measurements with purified recombinant pro-
teins, which were separately immobilized on the chip, in analyzing
binding constants to the soluble C-terminal portion of p33. Inter-
estingly, five of the known co-opted cellular factors bound with
2- to 7-fold-higher ka value to p33 than Rsp5p (Table 1). Among
these host proteins Tdh2p and Tef1p are present in large amounts
in cells, further increasing the chance that these host proteins bind
to p33 first or earlier than Rsp5p. This suggests that p33 likely have
a better chance to bind to the co-opted host factors at the early
FIG 7 Efficient copurification of selected co-opted host proteins with the viral replicase from yeast coexpressing TPR-domain protein or cyclophilin A (CypA).
The viral replicase was purified through FLAG-tagged p33 from yeast extracts using a FLAG-affinity column. (A to D) For the top panel, Western blot analysis
of copurified HA-tagged host protein expressed from the chromosomal location with anti-HA antibody was performed. For the middle panel, Western blot
analysis of the purified Flag-p33 using anti-FLAG antibody was performed. For the bottom panel, Western blot analysis of total protein extract with anti-HA
antibody was used to detect the total amount of the HA-tagged host protein expressed from the chromosomal location in each sample. Lane 1, negative control
based on yeast expressing His6-tagged p33 and the HA-tagged host protein; lane 2, yeast coexpressing Flag-p33 and the HA-tagged host protein; lane 3, yeast
coexpressing Flag-p33 and the HA-tagged host protein in combination with TPR-domain protein; lane 4, yeast coexpressing Flag-p33 and the HA-tagged host
protein in combination with CypA protein. All yeast strains actively replicate the TBSV repRNA (data not shown). Each experiment was repeated. (E) Western
blot analysis of total protein extracts from yeasts expressing the shown proteins through anti-His antibody.
TABLE 1 Kinetics of interaction between p33 replication protein and
cellular proteinsa
Protein or control KD (M)
Mean ka
(1/Ms) 	 SD kd (1/s)
Proteins
Rsp5 6.548e–7 2,203 	 96 1.442e–3
WW 5.200e–7 7,035 	 23 3.659e–3
Tdh2 3.806e–7 15,900 	 457 6.052e–3
Vps4 1.907e–7 11,380 	 234 2.170e–3
Tef1 3.633e–7 6,977 	 72 2.535e–3
Bro1 6.529e–7 5,961 	 151 3.892e–3
Cdc34 8.756e–7 4,549 	 217 3.983e–3
Pex19 3.822e–6 1,446  411 5.526e–3
Negative controls
WW:MBP 3.746e–6 417 1.566e–3
Cdc34:MBP 7.959e–6 737 5.867e–3
a KD, affinity of interaction constant; ka, association rate constant; kd, dissociation rate
constant.
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stage of infection when p33 concentration is low and the “free”
proviral cellular factors are still abundant.
The tombusvirus replicase purified at late stage of infection
is less precise when isolated from cells with depleted WW-do-
main proteins. To test whether Rsp5p might have a function in
regulation of VRC assembly and whether this function is mani-
fested at the late stage of infection, we purified tombusvirus rep-
licase from yeast with depleted WW-domain proteins (TET::
RSP5/TET::PRP40/wwm1) at early and late time points. Then,
the purified replicase preparations were tested with a ()RNA
template that is used to measure the precision of initiation events
by the RdRp (79, 80). While the replicase preparation from yeast
with depleted WW-domain proteins prepared at the early time
point (16 h) was 2-fold more active than the similar preparation
from wt yeast, the ratio of internal initiation and 3=terminal ex-
tension (3=-TEX) products versus full-length cRNA synthesis
product (this product is required for viral replication) was com-
parable by these replicases (Fig. 8B, lane 3 versus lane 1). Thus, the
replicase from yeast with depleted WW-domain proteins is more
active, but comparable in precision with the wt replicase.
Interestingly, the replicase preparation from yeast with de-
pleted WW-domain proteins prepared at the late time point (64 h)
was 4-fold more active than the similar preparation from wt
yeast. However, the replicase with depleted WW-domain proteins
was 2-fold less precise than the wt replicase, based on the ratio of
internal initiation and 3=-TEX versus full-length cRNA synthesis
(Fig. 8B, lane 5 versus lane 4). These data suggest that the WW-
domain proteins not only inhibit tombusvirus replicase assembly,
but surprisingly, they also help making the replicase more precise
at the late time points.
DISCUSSION
Rsp5p and WW-domain proteins act as CIRFs against tombus-
viruses. ()RNA viruses replicate the viral RNA efficiently in in-
fected cells via assembling membrane-bound VRCs consisting of
viral and subverted host proteins (1–7, 36, 81, 82). However, some
cellular factors could act as CIRFs restricting virus replication (22,
83, 84). Among the several CIRFs against tombusviruses, Rsp5p
and the WW-domain proteins are strong inhibitors, which are
present in both yeast and plant cells (64, 65). In the present study,
we show data that support the model that the cellular WW-do-
main proteins could inhibit assembly of new tombusvirus VRCs.
The presented data indicate that binding of the WW domain from
Rsp5p to p33 and p92pol (that contains p33 sequence due to the
overlapping expression strategy) blocks interaction of the replica-
tion proteins with (i) the viral RNA, (ii) the oligomerization with
other p33 and p92pol molecules, and (iii) a set of stimulatory (sus-
ceptibility) host factors subverted for TBSV replication. All of
these interactions are needed for the assembly of new VRCs and
the activation of p92pol, which is initially inactive in the cytosol
after translation (30, 37, 39, 56). Based on these features involving
many of the VRC components, the WW-domain proteins seem to
exhibit a complex mechanism as CIRFs.
Interestingly, overexpression of WW-domain protein inhib-
ited the subversion of several host proteins and their recruitment
into the VRCs (Fig. 5). Notably, the list of host factors affected by
the WW-domain protein includes co-opted host proteins, such as
eEF1A, Bro1p, Vps4p, and Cdc34p that play important roles in the
assembly of the tombusvirus VRCs in vitro, in yeast and plant cells
(4, 46, 47, 51, 53). We propose that overexpression of WW-do-
main proteins leads to strong competition between the WW-do-
main proteins and the co-opted susceptibility host factors in bind-
ing to the viral replication proteins even at the early stage of
replication due to the high abundance of free WW-domain pro-
teins in these cells (Fig. 9C). This should lead to inhibition of the
VRC assembly and reduced level of replication. Accordingly, over-
expression of Rsp5p and several other WW-domain proteins has
resulted in strong inhibition of TBSV RNA replication in yeast and
plants (64, 65). Simultaneous overexpression of both WW-do-
main protein and a co-opted host protein is also expected to lead
to strong competition in binding to the viral replication proteins
due to the high abundance of free WW-domain protein and the
FIG 8 Increased imprecise initiation by the tombusvirus replicase from yeast
with depleted WW-domain proteins. (A) Scheme of the tombusvirus replicase
assay. wt or mutant (TET::RSP5/TET::PRP40/wwm1 to deplete WW-domain
proteins) yeasts coexpressing FLAG-p33, FLAG-p92, and DI-72 repRNA were
used to purify the tombusvirus replicase after solubilization of the membrane
fraction of yeast. Note that yeasts were grown for 16 or 64 h after induction of
TBSV replication prior to replicase purification. The replicase preparations
were programmed with TBSV RI/III ()RNA that leads to precise initiation
[FL, full-length complementary ()RNA product] and imprecise initiations
(ii, internal initiation from cryptic promoter-like sequences; or 3=-TEX, 3=-
terminal extension). (B) Denaturing PAGE analysis of the in vitro replicase
products. The ratio of imprecise initiation versus precise initiation was calcu-
lated.
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given stimulatory host factor in these cells. Indeed, we observed
that overexpression of selected co-opted host proteins increased
TBSV replication even in the presence of abundant WW-domain
protein (Fig. 6). On the contrary, deletion or downregulation of
WW-domain proteins increased TBSV replication in yeast cells
(64, 65) or in vitro (Fig. 3 and 8). Thus, our data support that
Rsp5p and WW-domain proteins act as CIRFs under certain cel-
lular conditions.
Rsp5p and WW-domain proteins might also function as reg-
ulatory factors for TBSV replication. The VRC assembly is likely
highly regulated to prevent the extensive production of incom-
plete or truncated viral RNAs at the late stage of replication, when
one or more cellular components become limiting or even de-
pleted, making them unavailable for new rounds of VRC assembly
and virus replication. Our multiple genome-wide screens with
TBSV and yeast showed that missing a proviral host factor (due to
depletion or gene deletion) does not necessarily prevent the as-
sembly of the VRCs (11, 13, 40–42, 45, 48). Instead, it usually leads
to incorrect VRC assembly that changes some of the activities of
the viral replicase (such as increased rate of RNA recombination
or reduced efficiency of replication). It could be advantageous for
the virus to have an active mechanism(s) to regulate the assembly
of new VRCs toward the late phase of infection when several sub-
verted proviral host factors might be already depleted during the
previous rounds of VRC assembly.
Based on these ideas, we predict that somehow an RNA virus
could sense the state of the host cell and decide whether new VRCs
should be assembled or not. Based on the features presented in the
present study, Rsp5p and WW-domain proteins are likely highly
suitable for regulatory functions during TBSV replication. For
example, the regulatory role of the WW-domain proteins in TBSV
replication is supported by several interesting observations. (i)
Rsp5p binds to the p33 replication protein not as rapidly as several
proviral cellular factors (based on ka values in Table 1), suggesting
that the proviral factors might be favored by TBSV to act early
during replication, while Rsp5p might function at a latter stage of
infection when some of the proviral factors are mostly depleted.
(ii) The binding of a single Rsp5p or WW-domain protein likely
inhibits the function of a single p33 or p92pol replication protein
but does not have dominant-negative effect on the VRCs, as
FIG 9 Models for the role of WW-domain proteins in regulation of tombusvirus replication. We propose that WW-domain proteins inhibit the assembly of new
VRCs but do not affect already-assembled VRCs. (A) At the early stage of replication, the tombusvirus replication proteins bind primarily to the abundant cellular
susceptibility factors (proviral host factors [HFs]), to other viral replication proteins, and to the viral ()RNA to recruit the viral ()RNA to cellular membranes
and assemble functional VRCs. Binding to WW-domain proteins by the replication proteins is inefficient under these conditions. (B) At the late stage of
replication, the easily accessible host factors are depleted (scarce due to sequestration into previously assembled VRCs) and the new viral replication proteins bind
to WW-domain proteins, leading to a blockage in new VRC assembly. (C) Overexpression of the WW-domain proteins facilitates binding to the viral replication
proteins to WW-domain proteins (at the expense of interaction between replication proteins and host factors), leading to a blockage in VRC assembly and
reduced level of TBSV replication. Thus, WW-domain proteins can also act as CIRFs.
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shown by the use of WW-p33 fusion protein in a CFE-based viral
replication assay (Fig. 3). This could be important for tombusvi-
ruses, since the previously assembled VRCs should not be blocked
or destroyed by the regulatory protein. Instead, only the forma-
tion of new VRCs should be inhibited at the late stage of infection.
It is also possible that the WW-domain protein cannot access the
previously assembled VRCs, because those are closed from cyto-
solic proteins due to the spherule structure (57) or, alternatively,
the p33 and p92 proteins are already oligomerized (via p33-p33
self-interaction or p33-p92 interaction) or bound to proviral host
factors. (iii) A regulatory protein is expected to block the interac-
tion between the viral replication proteins and the viral RNA in
order to facilitate a nonreplicative use of the viral RNA (e.g., for
encapsidation or cell-to-cell movement), instead of keeping the
viral RNA trapped in the translation/replication cycle. (iv) It could
be useful if the regulatory protein would facilitate the degradation
of excess amounts of viral replication proteins to prevent the func-
tional interference of these replication proteins with other, non-
replicative functions. Indeed, p92pol is efficiently degraded when
Rsp5p or Wwm1p WW-domain proteins are overexpressed in
yeast (65). (v) It is predicted that VRCs assembled at the late stage
of infection could be especially error-prone if one or more provi-
ral cellular proteins are not recruited into VRCs due to their de-
pletion in previous rounds of VRC assembly. Accordingly, we de-
tected a higher error rate for incorrect initiation of RNA synthesis
with the purified replicase when derived from yeasts with depleted
WW-domain proteins at a late stage (Fig. 8). This aberrant feature
of the replicase could be due to incorrect assembly of the replicase
at the late stage, possibly due to depletion of one or more proviral
factors. Interestingly, we have shown that the WW-domain pro-
teins fulfill all of these features during TBSV replication.
Based on these observations, we suggest a new model for the
interplay between proviral factors and WW-domain proteins,
such as Rsp5p, in the regulation of tombusvirus VRC assembly.
We propose that the tombusvirus replication proteins first inter-
act with the host susceptibility factors, which are co-opted for
virus replication at the beginning of infection when these suscep-
tibility factors are abundant and/or accessible (Fig. 9A). These
events lead to efficient assembly of VRCs and robust viral replica-
tion at the early stage of replication. As the amounts of newly
produced p33 and p92pol replication proteins increase due to on-
going translation, the cell likely runs out of one or more available
susceptibility factors at the late stage of replication. Depletion of
the susceptibility factors allows the viral replication proteins to
interact with the cellular WW-domain proteins (Fig. 9B). This will
then lead to a blockage for the assembly of new VRCs and inhibi-
tion of the formation of new p33-viral RNA complexes and to the
degradation of p92pol replication protein. Thus, viral replication,
especially the formation of new VRCs, will be slowed down at the
late stage, and the newly made viral ()RNAs will be able to leave
the translation/replication cycle and can become committed to
additional functions, such as encapsidation or cell-to-cell move-
ment. Altogether, we propose that tombusviruses could sense the
status of the infected cells via “measuring” the availability of cel-
lular susceptibility factors versus cellular WW-domain proteins,
which then determines whether new VRCs are assembled or the
VRC assembly process is halted.
Why would an RNA virus select WW-domain proteins for
such a regulatory function? We propose that the WW-domain
proteins are very suitable for these functions, since they are pres-
ent in the cytosol of all eukaryotic cells, and they also represent an
ancient, very simple motif selected for protein-protein interac-
tions (66, 72, 85). Indeed, we were able to identify several WW-
domain proteins in both yeasts and plants (65), which could be
used by tombusviruses for such regulatory roles. Interestingly, the
unrelated nodaviruses (insect RNA viruses) could also be inhib-
ited by overexpression of yeast Rsp5p and Wwm1p WW-domain
proteins (65). The question remains if additional RNA viruses
could also take advantage of WW-domain proteins or other cel-
lular proteins for regulatory functions to optimize their replica-
tion in various cells and hosts.
Unlike the WW-domain proteins, other inhibitory cellular
CIRF proteins, such as the TPR-domain containing Cyp40-like
Cpr7p chaperone or CypA cyclophilin (45, 77), do not seem to
affect the recruitment of stimulatory host factors into the VRCs
(Fig. 7). Thus, these cellular restriction factors are not involved in
regulation of tombusvirus replication in a manner similar to WW-
domain proteins, or they function utilizing different regulatory
mechanisms.
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